Combination Product: continuous oral delivery of levodopa/carbidopa ( DrugBank: Carbidopa, Levodopa )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
6パーキンソン病1

6. パーキンソン病


臨床試験数 : 2,298 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04778176
(ClinicalTrials.gov)
June 16, 202122/2/2021Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease PatientsAssessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease PatientsParkinson's DiseaseCombination Product: continuous oral delivery of levodopa/carbidopaSynAgile CorporationClintrex Research Corporation;TFS Trial Form Support;Clinical Data Science GmbHRecruiting30 YearsN/AAll24Phase 2Italy;Luxembourg